세계의 갱년기 안면 홍조 시장 보고서(2025년)

Menopausal hot flashes, also known as vasomotor symptoms, are common experiences during menopause and perimenopause. These symptoms manifest as intense bursts of heat, sweating, and heated skin in women. Hot flashes can be bothersome, causing discomfort, anxiety, and disruption of sleep.

The main types of treatment for menopausal hot flashes encompass hormonal treatment, non-hormonal treatment, and alternative treatment. Hormonal treatment involves therapy for women during the menopausal period when the body ceases to produce estrogen. This therapy typically includes the administration of medications containing female hormones to replace the declining estrogen levels. Pipeline analysis in this context involves the examination of drugs in different phases of development, including phase III drugs and phase I and II drugs. These treatments are typically made available through various distribution channels, such as retail pharmacies, online pharmacies, and hospital pharmacies. The applications of these treatments can be tailored to different age groups, including 51-55-year-old women, 46-50-year-old women, and 40-45-year-old women, depending on individual needs and circumstances.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The menopausal hot flashes market research report is one of a series of new reports from The Business Research Company that provides menopausal hot flashes market statistics, including menopausal hot flashes industry global market size, regional shares, competitors with menopausal hot flashes market share, detailed menopausal hot flashes market segments, market trends, and opportunities, and any further data you may need to thrive in the menopausal hot flashes industry. This menopausal hot flashes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The menopausal hot flashes market size has grown strongly in recent years. It will grow from $15.08 billion in 2024 to $15.92 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to hormone replacement therapy, limited treatment options, awareness and education, shift in lifestyle management, alternative therapies:.

The menopausal hot flashes market size is expected to see strong growth in the next few years. It will grow to $20.28 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to advancements in non-hormonal therapies, individualized treatment approaches, focus on natural remedies, research on neurotransmitter pathways. Major trends in the forecast period include non-pharmacological interventions, digital health solutions, novel drug formulations, precision medicine in menopause, combination therapies.

The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of hormone replacement therapies and non-hormonal neurokinin inhibitors sourced from the UK and Denmark, exacerbating menopausal symptom management costs and limiting treatment access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The government's initiatives for women's health in menopause are expected to propel the growth of the menopausal hot flashes market going forward. The government's menopausal health initiatives include financing for novel studies to understand the menopausal transition and avoid illness and support for investigations of linked pharmacological, clinical, and epidemiological aspects and preventive research. Government initiatives for women's health frequently cover a wide variety of concerns, such as menopause health and the management of symptoms such as hot flashes, as well as efforts to promote health through risk factor research, prevention, and early diagnosis of significant health conditions. For instance, in January 2023, according to the Government of New South Wales, an Australia-based government agency, the government initiated $40.3 million over four years (2022-2023 to 2025-2026) to build up to 16 new programs for women facing severe menopausal symptoms. Therefore, the government's initiatives for women's health in menopause are driving the growth of the menopausal hot flashes market.

The rising healthcare expenditure is anticipated to drive the growth of the menopausal hot flashes market in the future. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, usually at a national or regional level. Increased investment in healthcare can result in advanced treatment options, greater awareness of menopausal symptoms, enhanced research initiatives, improved access to healthcare services, alternative therapies, and better support programs. This can significantly improve the quality of life for women experiencing menopausal hot flashes by offering more effective treatments and supportive care services. For example, in May 2023, a report by the Office for National Statistics, a UK-based government department, revealed that healthcare spending in the UK increased by 5.6% from 2022 to 2023, compared to 0.9% growth in 2022. The total UK healthcare expenditure reached approximately $317.63 billion (£292 billion) in 2023. Therefore, the growing healthcare expenditure is contributing to the expansion of the menopausal hot flashes market.

The menopausal hot flashes market witnesses a rising inclination towards product innovations, constituting a significant trend. Notably, prominent entities within this market are actively introducing inventive solutions to fortify their market standing. An instance of this was observed in May 2023 when Astellas Pharma US Inc., a US-based pharmaceutical establishment, announced the FDA's approval of Veozah. This novel treatment, designed for menopause-induced hot flashes, marks the pioneering approval of a neurokinin 3 (NK3) receptor inhibitor for managing mild to severe hot flashes related to menopause. Its mechanism involves binding to and activating the NK3 receptor, integral in regulating body temperature within the brain.

Major industry players are strategically forging alliances to drive new product development initiatives and bolster their market presence. Such collaborations and partnerships in this domain serve to stimulate innovation, harness synergistic expertise, and expedite the progression and commercial launch of advanced therapies. For instance, in July 2022, Lisa Health Inc., a US-based digital health entity, entered a collaborative venture with Mayo Clinic, a US-based academic medical institution, to introduce 'Midday.' This app-based innovation caters to personalized menopausal management through the integration of digital therapeutics and artificial intelligence (AI). By leveraging intricate algorithms and sensor technology customized to individual stages and symptoms, Midday endeavors to address gaps in care, offering tailored guidance, educational resources, and strategies. Additionally, Midday provides users access to Mayo Clinic's technology platform, facilitating education on menopausal hormone treatment and aiding users in making informed decisions regarding its suitability.

In October 2022, Unified Women's Healthcare, a prominent US-based healthcare company specializing in women's healthcare treatment, successfully acquired Gennev for an undisclosed amount. Through this strategic acquisition, Unified Women's Healthcare aims to broaden its women's healthcare portfolio, with the objective of enhancing outcomes and the overall patient experience at every stage of a woman's healthcare journey. Gennev, the acquired company, is based in the United States and provides feminine care services, offering various treatments to empower women to take control of their health throughout and after the menopausal transition.

Major companies operating in the menopausal hot flashes market include Pfizer Inc., Johnson & Johnson, The Procter & Gamble Company, Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., Gedeon Richter Plc, Lupin Limited, Hisamitsu Pharmaceutical Co. Inc., Noven Pharmaceuticals Inc., Ligand Pharmaceuticals Inc., Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex Ltd., Ascend Therapeutics Inc., EndoCeutics Inc., Sermonix Pharmaceuticals LLC, Ralington pharma LLP

North America was the largest region in the Menopausal Hot Flashes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopausal hot flashes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the menopausal hot flashes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The menopausal hot flashes market consists of revenues earned by entities by providing estrogen therapy, and menopause hormone therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The menopausal hot flashes market also includes sales of venlafaxine, paroxetine, and escitalopram. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopausal Hot Flashes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on menopausal hot flashes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopausal hot flashes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The menopausal hot flashes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hormonal Treatment; Non-Hormonal Treatment; Alternative Treatment
• 2) By Pipeline Analysis: Phase III Drugs; Phase I And II Drugs
• 3) By Distribution Channel: Retail Pharmacies; Online Pharmacies; Hospital Pharmacies
• 4) By Application: 51-55 Year Old Woman; 46-50 Year Old Woman; 40-45 Year Old Woman
• Subsegments:
• 1) By Hormonal Treatment: Estrogen Therapy; Combined Hormonal Therapy
• 2) By Non-Hormonal Treatment: Selective Serotonin Reuptake Inhibitors; Gabapentinoids; Clonidine
• 3) By Alternative Treatment: Herbal Supplements; Acupuncture; Lifestyle Modifications
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; The Procter & Gamble Company; Merck & Co. Inc.; Bayer AG; Novartis AG; AstraZeneca plc; GlaxoSmithKline plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Co Ltd.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Eisai Co. Ltd.; Otsuka Pharmaceutical Co. Ltd.; Shionogi & Co. Ltd.; Gedeon Richter Plc; Lupin Limited; Hisamitsu Pharmaceutical Co. Inc.; Noven Pharmaceuticals Inc.; Ligand Pharmaceuticals Inc.; Mithra Pharmaceuticals SA; TherapeuticsMD Inc.; Theramex Ltd.; Ascend Therapeutics Inc.; EndoCeutics Inc.; Sermonix Pharmaceuticals LLC; Ralington pharma LLP
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Menopausal Hot Flashes Market Characteristics

3. Menopausal Hot Flashes Market Trends And Strategies

4. Menopausal Hot Flashes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Menopausal Hot Flashes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Menopausal Hot Flashes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Menopausal Hot Flashes Market Growth Rate Analysis
• 5.4. Global Menopausal Hot Flashes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Menopausal Hot Flashes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Menopausal Hot Flashes Total Addressable Market (TAM)

6. Menopausal Hot Flashes Market Segmentation

• 6.1. Global Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatment
• Non-Hormonal Treatment
• Alternative Treatment
• 6.2. Global Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase III Drugs
• Phase I And II Drugs
• 6.3. Global Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies
• 6.4. Global Menopausal Hot Flashes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 51-55 Year Old Woman
• 46-50 Year Old Woman
• 40-45 Year Old Woman
• 6.5. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Therapy
• Combined Hormonal Therapy
• 6.6. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Non-Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Serotonin Reuptake Inhibitors
• Gabapentinoids
• Clonidine
• 6.7. Global Menopausal Hot Flashes Market, Sub-Segmentation Of Alternative Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Supplements
• Acupuncture
• Lifestyle Modifications

7. Menopausal Hot Flashes Market Regional And Country Analysis

• 7.1. Global Menopausal Hot Flashes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Menopausal Hot Flashes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Menopausal Hot Flashes Market

• 8.1. Asia-Pacific Menopausal Hot Flashes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Menopausal Hot Flashes Market

• 9.1. China Menopausal Hot Flashes Market Overview
• 9.2. China Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Menopausal Hot Flashes Market

• 10.1. India Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Menopausal Hot Flashes Market

• 11.1. Japan Menopausal Hot Flashes Market Overview
• 11.2. Japan Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Menopausal Hot Flashes Market

• 12.1. Australia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Menopausal Hot Flashes Market

• 13.1. Indonesia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Menopausal Hot Flashes Market

• 14.1. South Korea Menopausal Hot Flashes Market Overview
• 14.2. South Korea Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Menopausal Hot Flashes Market

• 15.1. Western Europe Menopausal Hot Flashes Market Overview
• 15.2. Western Europe Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Menopausal Hot Flashes Market

• 16.1. UK Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Menopausal Hot Flashes Market

• 17.1. Germany Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Menopausal Hot Flashes Market

• 18.1. France Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Menopausal Hot Flashes Market

• 19.1. Italy Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Menopausal Hot Flashes Market

• 20.1. Spain Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Menopausal Hot Flashes Market

• 21.1. Eastern Europe Menopausal Hot Flashes Market Overview
• 21.2. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Menopausal Hot Flashes Market

• 22.1. Russia Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Menopausal Hot Flashes Market

• 23.1. North America Menopausal Hot Flashes Market Overview
• 23.2. North America Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Menopausal Hot Flashes Market

• 24.1. USA Menopausal Hot Flashes Market Overview
• 24.2. USA Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Menopausal Hot Flashes Market

• 25.1. Canada Menopausal Hot Flashes Market Overview
• 25.2. Canada Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Menopausal Hot Flashes Market

• 26.1. South America Menopausal Hot Flashes Market Overview
• 26.2. South America Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Menopausal Hot Flashes Market

• 27.1. Brazil Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Menopausal Hot Flashes Market

• 28.1. Middle East Menopausal Hot Flashes Market Overview
• 28.2. Middle East Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Menopausal Hot Flashes Market

• 29.1. Africa Menopausal Hot Flashes Market Overview
• 29.2. Africa Menopausal Hot Flashes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Menopausal Hot Flashes Market, Segmentation By Pipeline Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Menopausal Hot Flashes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Menopausal Hot Flashes Market Competitive Landscape And Company Profiles

• 30.1. Menopausal Hot Flashes Market Competitive Landscape
• 30.2. Menopausal Hot Flashes Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Menopausal Hot Flashes Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca plc
• 31.3. GlaxoSmithKline plc.
• 31.4. Takeda Pharmaceutical Company Limited
• 31.5. Eli Lilly and Co Ltd.
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Astellas Pharma Inc.
• 31.9. Eisai Co. Ltd.
• 31.10. Otsuka Pharmaceutical Co. Ltd.
• 31.11. Shionogi & Co. Ltd.
• 31.12. Gedeon Richter Plc
• 31.13. Lupin Limited
• 31.14. Hisamitsu Pharmaceutical Co. Inc.
• 31.15. Noven Pharmaceuticals Inc.

32. Global Menopausal Hot Flashes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Menopausal Hot Flashes Market

34. Recent Developments In The Menopausal Hot Flashes Market

35. Menopausal Hot Flashes Market High Potential Countries, Segments and Strategies

• 35.1 Menopausal Hot Flashes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Menopausal Hot Flashes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Menopausal Hot Flashes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer